107 related articles for article (PubMed ID: 9413939)
1. Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.
Moerland E; Breuning MH; Cornelisse CJ; Cleton-Jansen AM
Br J Cancer; 1997; 76(12):1550-3. PubMed ID: 9413939
[TBL] [Abstract][Full Text] [Related]
2. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
[TBL] [Abstract][Full Text] [Related]
3. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.
Cleton-Jansen AM; Moerland EW; Pronk JC; van Berkel CG; Apostolou S; Crawford J; Savoia A; Auerbach AD; Mathew CG; Callen DF; Cornelisse CJ
Br J Cancer; 1999 Mar; 79(7-8):1049-52. PubMed ID: 10098735
[TBL] [Abstract][Full Text] [Related]
5. Detection of a 4-bp insertion (CACA) functional polymorphism at nucleotide 241 of the cellular adhesion regulatory molecule CMAR (formerly CAR).
Durbin H; Novelli M; Bodmer W
Genomics; 1994 Jan; 19(1):181-2. PubMed ID: 7993411
[No Abstract] [Full Text] [Related]
6. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
[TBL] [Abstract][Full Text] [Related]
7. Expression of cellular adhesion regulatory molecule in hepatocellular carcinoma.
Sunaga M; Yoshikawa M; Ebara M; Kondo F; Kashiwada M; Takemori T; Saisho H
J Gastroenterol Hepatol; 1998 Sep; 13(9):878-84. PubMed ID: 9794184
[TBL] [Abstract][Full Text] [Related]
8. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.
Cleton-Jansen AM; Collins N; Lakhani SR; Weissenbach J; Devilee P; Cornelisse CJ; Stratton MR
Br J Cancer; 1995 Nov; 72(5):1241-4. PubMed ID: 7577475
[TBL] [Abstract][Full Text] [Related]
11. Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3.
Savino M; d'Apolito M; Centra M; van Beerendonk HM; Cleton-Jansen AM; Whitmore SA; Crawford J; Callen DF; Zelante L; Savoia A
Genomics; 1999 Oct; 61(2):219-26. PubMed ID: 10534407
[TBL] [Abstract][Full Text] [Related]
12. The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer.
Crawford J; Ianzano L; Savino M; Whitmore S; Cleton-Jansen AM; Settasatian C; d'apolito M; Seshadri R; Pronk JC; Auerbach AD; Verlander PC; Mathew CG; Tipping AJ; Doggett NA; Zelante L; Callen DF; Savoia A
Genomics; 1999 Feb; 56(1):90-7. PubMed ID: 10036189
[TBL] [Abstract][Full Text] [Related]
13. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
[TBL] [Abstract][Full Text] [Related]
14. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
[TBL] [Abstract][Full Text] [Related]
15. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
16. Defining regions of loss of heterozygosity of 16q in breast cancer cell lines.
Callen DF; Crawford J; Derwas C; Cleton-Jansen AM; Cornelisse CJ; Baker E
Cancer Genet Cytogenet; 2002 Feb; 133(1):76-82. PubMed ID: 11890994
[TBL] [Abstract][Full Text] [Related]
17. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
18. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
[TBL] [Abstract][Full Text] [Related]
19. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
20. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma.
Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A
Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
